Policies & Research

New experimental treatment offers hope for advanced liver cancer

Sydney-based researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer, and the third leading cause of cancer death worldwide. Hepatocellular carcinomas …

Past Hep B No Cancer Risk for People Cured of Hep C

For a long time it has been standard practice to recommend anyone living with hepatitis C to get vaccinated against hepatitis B, as the two viruses together can put more …

Shock! Horror!: Media Stigmatising of AOD Users

Negative media portrayal of drug use perpetuates the issues it claims to oppose. South Australian study makes recommendations for change.

Cash Rewards for Hep C Treatment

A study is exploring whether cash rewards would motivate people to start hepatitis C treatment, and if it does, what level of payment is needed.

SAPOL Education

The Hepatitis SA Education team to deliver ongoing blood safety and viral hepatitis training and education to all operational SAPOL personnel.

Alcohol No Barrier to SVR

Research finds alcohol does not reduce chances of successful hepatitis C treatment.

Liver Cancer Control Roadmap

The elimination of hepatitis B and hepatitis C is one of the key strategies outlined in a set of guidelines addressing the alarming rise of liver cancer cases and associated …

Hepatitis C Drug Resistance

Direct-acting antiviral drugs (DAAs) to treat hepatitis C have proven to be a spectacular success, being able to cure more than 95% of people who have been living with the …

Asia-Pacific Consensus

Hep Can’t Wait is the international campaign launched by the World Hepatitis Alliance in 2021. Its aim is to highlight the social injustice and inequity caused by the current lack …

Hepatitis B Trends Falling Short

The Viral Hepatitis Mapping Project looks at geographic variations in the prevalence of viral hepatitis across Australia, as well as access to care, to identify priority areas for response. It is a …